Diabetes Care, Vol 22, Issue 10 1703-1707, Copyright © 1999 by American Diabetes Association

ARTICLES

Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study

HF Allen, GJ Klingensmith, P Jensen, E Simoes, A Hayward and HP Chase
Baystate Medical Center Children's Hospital, Springfield, MA 01095, USA. holley.allen@bhs.org

OBJECTIVE: We undertook this study to test whether Bacillus Calmette-Guerin (BCG) vaccine preserves beta-cell function and increases the remission rate in children with new-onset type 1 diabetes. RESEARCH DESIGN AND METHODS: This was a randomized double-blind placebo-controlled trial offered to children referred to the Barbara Davis Center for Childhood Diabetes or the Baystate Medical Center with a diagnosis of new-onset type 1 diabetes. There were 94 children aged 5-18 years who received either BCG or saline intradermally within 4 months of onset of symptoms and who were then evaluated at 3-month intervals for 2 years. The primary end point was remission, defined as insulin independence for 4 weeks. Secondary end points were C-peptide levels (fasting and in response to a mixed meal challenge), insulin dose, and HbA1c. RESULTS: Of the patients, 47 were randomized to each arm; 7 in the placebo group and 9 in the BCG group did not complete 1 year of the study and are not included in the analysis. One patient from each group achieved remission. Fasting and stimulated C-peptide levels did not differ by treatment arm but declined in both groups and were lower initially and during the entire 2-year period in younger children. Insulin requirements and HbA1c levels did not differ in the two groups. CONCLUSIONS: Vaccination with BCG at the time of onset of type 1 diabetes does not increase the remission rate or preserve beta-cell function.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. P. Mordes, D. L. Guberski, J. H. Leif, B. A. Woda, J. F. Flanagan, D. L. Greiner, E. H. Kislauskis, and R. S. Tirabassi LEW.1WR1 Rats Develop Autoimmune Diabetes Spontaneously and in Response to Environmental Perturbation Diabetes, September 1, 2005; 54(9): 2727 - 2733. [Abstract] [Full Text] [PDF]

				M. Huppmann, A. Baumgarten, A.-G. Ziegler, and E. Bonifacio Neonatal Bacille Calmette-Guerin Vaccination and Type 1 Diabetes Diabetes Care, May 1, 2005; 28(5): 1204 - 1206. [Full Text] [PDF]

				C. J. Greenbaum and L. C. Harrison Guidelines for Intervention Trials in Subjects With Newly Diagnosed Type 1 Diabetes Diabetes, May 1, 2003; 52(5): 1059 - 1065. [Full Text] [PDF]

				P. A. Offit and C. J. Hackett Addressing Parents' Concerns: Do Vaccines Cause Allergic or Autoimmune Diseases? Pediatrics, March 1, 2003; 111(3): 653 - 659. [Abstract] [Full Text] [PDF]

				J.-F. Bach The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases N. Engl. J. Med., September 19, 2002; 347(12): 911 - 920. [Full Text] [PDF]